PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Laboratory of Molecular Immunopharmacology and Drug Discovery, Department of Immunology, Tufts University School of Medicine, Boston, Massachusetts, USA.\', \'School of Graduate Biomedical Sciences, Tufts University School of Medicine, Boston, Massachusetts, USA.\', \'Department of Internal Medicine, Tufts University School of Medicine and Tufts Medical Center, Boston, Massachusetts, USA.\', \'Department of Psychiatry, Tufts University School of Medicine and Tufts Medical Center, Boston, Massachusetts, USA.\', \'BrainGate, Thessaloniki, Greece.\', \'First Department of Psychiatry, Eginition Hospital, National and Kapodistrian University, Athens, Greece.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/biof.1726
?:doi
?:hasPublicationType
?:journal
  • BioFactors (Oxford, England)
is ?:pmid of
?:pmid
?:pmid
  • 33847020
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Long-COVID syndrome-associated brain fog and chemofog: Luteolin to the rescue.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all